ACRIX
Price
$27.65
Change
+$0.12 (+0.44%)
Updated
Jul 31 closing price
Net Assets
1.55B
GAGAX
Price
$38.77
Change
-$0.17 (-0.44%)
Updated
Jul 31 closing price
Net Assets
75.68M
Interact to see
Advertisement

ACRIX vs GAGAX

ACRIX vs GAGAX Comparison Chart in %
View a ticker or compare two or three
VS
ACRIX vs. GAGAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRIX is a Hold and GAGAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ACRIX has more cash in the bank: 1.55B vs. GAGAX (75.7M). GAGAX pays higher dividends than ACRIX: GAGAX (2.01) vs ACRIX (0.68). ACRIX was incepted earlier than GAGAX: ACRIX (10 years) vs GAGAX (25 years). GAGAX (1.60) is less costly to investors than ACRIX (1.15). ACRIX is a more actively managed with annual turnover of: 172.00 vs. GAGAX (5.00). GAGAX has a lower initial minimum investment than ACRIX: GAGAX (1000) vs ACRIX (10000000). GAGAX annual gain was more profitable for investors over the last year : 15.79 vs. ACRIX (9.58). GAGAX return over 5 years is better than : 25.14 vs. ACRIX (10.24).
ACRIXGAGAXACRIX / GAGAX
Total Expense Ratio1.150.90128%
Annual Report Gross Expense Ratio1.151.6072%
Fund Existence10 years25 years-
Gain YTD9.7668.599114%
Front LoadN/A6%-
Min. Initial Investment1000000010001,000,000%
Min. Initial Investment IRAN/A250-
Net Assets1.55B75.7M2,049%
Annual Yield % from dividends0.682.0134%
Returns for 1 year9.5815.7961%
Returns for 3 years25.3633.5076%
Returns for 5 years10.2425.1441%
Returns for 10 yearsN/A90.54-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WBENX18.800.34
+1.84%
William Blair Emerging Mkts Growth N
TEWTX17.360.23
+1.34%
Templeton World C
COFRX43.810.43
+0.99%
Columbia Contrarian Core Inst2
LSOFX14.990.14
+0.94%
LS Opportunity Fund Institutional Class
PPAJX23.930.06
+0.25%
GMO U.S. Opportunistic Value R6